Makers Laboratories Ltd. (BSE: 506919) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹187 Cr, it ranks #2,712 by market cap among the 6,197 Indian listed companies on FinBizNet, and #37 of 63 in Pharmaceuticals. At ₹301.08 (as of 16 Nov 2026), the share price is 10.1% below its 52-week high of ₹335.00 and 100.7% above its 52-week low of ₹150.00. The share price is up 27.7% over one year and up 24.6% over three months.
| Current Price | ₹301.08 |
|---|---|
| Market Cap | ₹187 Cr |
| BSE Code | 506919 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 79.2 |
| Return on Equity | 9.94% |
| Return on Assets | 4.15% |
| 52-Week Range | ₹150.00 – ₹335.00 |
| 1-Year Price Change | +27.7% |
| 3-Month Price Change | +24.6% |
| Beta (1Y) | 0.2 |
| Dividend Yield | 0.00% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.makerslabs.com |
Delivery averaged 64.5% of traded volume across 15 NSE sessions (22 Oct 2026 – 12 Nov 2026).
Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, digestives, neurotonics, nutritional supplements, topical anti-biotic/anti-microbial, and other specialty drugs. The company sells its products under the Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin brands. It distributes its products through agents, stockiest, doctors, and retailers. The company was incorporated in 1984 and is based in Mumbai, India.
1. Pharmaceutical-This segment offers pharmaceutical products. 2. Chemical Manufacturing-This segment engages in the chemical manufacturing business. 3. Segment Adjustment-0
1. Pharmaceutical-35.8% 2. Chemical Manufacturing-64.2%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹56,531 Cr | 36.3 | 34.46% | ₹1,814 Cr | -8.1% |
| Emcure Pharmaceuticals Ltd | ₹42,344 Cr | 47.9 | 19.57% | ₹2,820 Cr | +73.3% |
| Ajanta Pharma Limited | ₹41,474 Cr | 39.4 | 25.39% | ₹1,794 Cr | +27.8% |
| Piramal Pharma Ltd | ₹32,600 Cr | n/m | -4.00% | ₹2,617 Cr | +22.8% |
| RUBICON RESEARCH LIMITED | ₹28,526 Cr | 112.3 | 19.14% | ₹576 Cr | +162.7% |
| Caplin Point Laboratories Ltdte | ₹18,155 Cr | 28.3 | 19.94% | ₹630 Cr | +23.6% |
| Pfizer Ltd. | ₹17,811 Cr | 24.5 | 17.16% | ₹727 Cr | -24.2% |
| Eris Lifesciences Ltd | ₹17,691 Cr | 28.3 | 18.07% | ₹892 Cr | -17.5% |
| Makers Laboratories Ltd. | ₹187 Cr | 79.2 | 9.94% | — | +27.7% |
Listed by market capitalisation. Ratios are shown for context only.
Makers Laboratories Ltd. is trading at ₹301.08, with a market capitalisation of ₹187 Cr.
Makers Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Makers Laboratories Ltd. has a P/E of 79.2 and a return on equity of 9.94%.
Makers Laboratories Ltd. is listed on the BSE under the scrip code 506919.
Makers Laboratories Ltd.'s share price is up 27.7% over one year and up 24.6% over three months. Its 52-week range is ₹150.00 to ₹335.00.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.